Results 231 to 240 of about 218,075 (284)

Malignant histiocytic neoplasm with dendritic differentiation via transdifferentiation of B-cell lymphoma. [PDF]

BMJ Case Rep
Wu C, Cui W, Tun AM.
europepmc   +1 more source

Acute monocytic leukemia with t(8;22)(p11;q11)/BCR::FGFR1, trisomy 8, and concurrent RUNX1/STAG2 mutations: A rare case report and literature review. [PDF]

Leuk Res Rep
Kunda SPR, Patibandla S, Gottipati RM, Johari S, Kasaragadda M, Kg K, Singh S.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Neurologic complications of hematologic neoplasms

Neurologic Clinics, 2003
The new WHO classification of hematopoietic and lymphatic neoplasms was devised to offer pathologists, oncologists, and geneticists a system of classification based on histopathologic, clinical, and genetic features. From the neurologic standpoint, it offers an opportunity to consolidate the complications produced by leukemias, lymphomas, and plasma ...
Lawrence, Recht, Maciej, Mrugala
openaire   +2 more sources

Immunologic Aspects of the Hematologic Neoplasms

Postgraduate Medicine, 1973
Understanding the pathogenesis and pathophysiology of the hematologic malignancies now requires knowledge of their immunology. Many of these tumors appear to arise from the immune cells themselves (B or T cell tumors); most have associated disturbances in immune cell function.
S E, Jones, B G, Durie, S E, Salmon
openaire   +2 more sources

Rheumatologic Manifestations of Hematologic Neoplasms

Current Rheumatology Reviews, 2017
The rheumatologic manifestations of hematologic neoplasms are a collection of diverse syndromes. This review aims to describe the most common syndromes in the context of potential mechanisms of pathogenesis.We undertook a structured search of the available peer-reviewed literature describing paraneoplastic phenomena associated with hematologic ...
A, Wang, C M, Brunet, A M, Zeidan
openaire   +2 more sources

BRAF — A new player in hematological neoplasms

Blood Cells, Molecules, and Diseases, 2014
BRAF oncogenic kinase has become a target for specific therapy in oncology. Genetic characterization of a predominant V600E mutation in melanoma, thyroid cancer, and other tumors became a focus for developing specific inhibitors, such as vemurafenib or dabrafenib.
Marcin M. Machnicki, Tomasz Stoklosa
openaire   +2 more sources

Flow Cytometric Immunophenotyping for Hematologic Neoplasms

Blood, 2008
AbstractFlow cytometric immunophenotyping remains an indispensable tool for the diagnosis, classification, staging, and monitoring of hematologic neoplasms. The last 10 years have seen advances in flow cytometry instrumentation and availability of an expanded range of antibodies and fluorochromes that have improved our ability to identify different ...
Fiona E Craig
exaly   +3 more sources

Cutaneous manifestations and management of hematologic neoplasms

Seminars in Oncology, 2016
Many malignant hematologic neoplasms can directly and indirectly involve the skin with lesions that are disfiguring, painful, and compromise integumentary function. The majority of lymphomas that directly infiltrate the skin are of T-cell origin but B-cell lymphomas, and other hematologic neoplasms, including acute myeloid and lymphoblastic leukemias ...
Olalekan O, Oluwole, John A, Zic, Jonathan J, Douds, Mary, Ann Thompson, John P, Greer   +4 more
openaire   +2 more sources

[Hematologic changes in renal neoplasms].

Minerva medica, 1984
The main haematological parameters, particularly haemoglobin concentration and the numbers of leukocytes and platelets, were studied in 146 kidney tumour patients. Only 119 of the subjects studied later underwent nephrectomy. In 66 patients the tumours were limited to within the renal capsule (group I) while in 39 other subjects the tumours had gone ...
PICCININI, Lino, Croci E, Tavoni F, SACCHI, Stefano, Curci G.   +4 more
openaire   +2 more sources